• Eli Lilly’s President of Oncology to retire pharmafile
    June 07, 2018
    Just as it ramps up its cancer-fighting efforts, Eli Lilly has revealed that its Senior Vice President and President of Lilly Oncology Sue Mahony is set to retire from her role, effective 31 August.
  • Eli Lilly to buy AurKa Pharma financialexpress
    May 21, 2018
    Eli Lilly and Company has signed an agreement to acquire AurKa Pharma, established by TVM Capital Life Science to develop oncology compound AK-01, an Aurora kinase A inhibitor that was originally discovered at Lilly.
PharmaSources Customer Service